about
NY-ESO-1 expression in DCIS: A new predictor of good prognosis.Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre study.Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta.Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.Childhood impulsive behavior and problem gambling by adulthood: a 30-year prospective community-based study.In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta.Ambient particulate matter and the response to orthostatic challenge in the elderly: the Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly (MOBILIZE) of Boston study.Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.Gestational length assignment based on last menstrual period, first trimester crown-rump length, ovulation, and implantation timing.Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.Poised epigenetic states and acquired drug resistance in cancer.Challenges and methodology in the incorporation of biomarkers in cancer clinical trials.A model to predict vaginal delivery in nulliparous women based on maternal characteristics and intrapartum ultrasound.Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer.Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients.Genes predisposed to DNA hypermethylation during acquired resistance to chemotherapy are identified in ovarian tumors by bivalent chromatin domains at initial diagnosis.Whole-genome characterization of chemoresistant ovarian cancer.Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.Erratum: Corrigendum: Whole–genome characterization of chemoresistant ovarian cancerUltrasound is better tolerated than vaginal examination in and before labourExamining the interaction between TGFBR3 and ESRRA in ovarian cancer prognosisThe prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancerPrediction of mode of delivery using the first ultrasound-based "intrapartum app"The Impact of Focality and Centricity on Vulvar Intraepithelial Neoplasia on Disease Progression in HIV+ Patients: A 10-Year Retrospective Study
P50
Q33718676-39E41F48-F366-4F8B-A69D-FEF5B0ED0BDCQ33829751-EF56FE5A-E724-449E-8F4A-8459EA10F052Q35064722-9C94A1AD-FF88-41D8-B0D1-0B6405EA96F3Q35118861-9183AD4C-E3E3-4EAD-A8F8-ED28F5FDA6E8Q35585074-4A0F7DE5-BD0D-4258-9714-840B01A68119Q35654234-59E886FB-A5B9-4421-8A37-C2184A02EA6AQ35756857-4D0A1D8E-B6B9-4523-8522-BD3F37573534Q35775914-1B7A45F8-8DE2-4FFE-8119-5BFE8848B807Q36288013-2929DF5E-EC31-4353-AE4D-DBA35BED9861Q37245896-C29CF5D8-2E10-4740-A671-33C5C88C5D67Q37273861-285CCE38-69A3-4C1A-9526-55D1336FF593Q38254072-2F160F48-C5F8-4A8A-910F-77FFA9B8C493Q39097367-9B0701BB-070D-4FA8-8762-E5C498B3C2E2Q40283053-EF0E7DAA-F66F-4347-B8FB-5D588E13B14BQ40768444-CCFA93E2-55DE-4F26-82E1-2066548E010CQ48922857-B7285737-3FDB-429F-9AFC-1F1B05A422E4Q50019974-1FBB0477-9BFF-47F5-8CE6-86EB3BF4ACD0Q50272478-15570349-91E1-4972-81FA-46747D51898AQ53055914-3F86EE73-4CDC-4255-8E21-20F1A38BA136Q56773401-D0E89665-A856-4961-884A-A04B67B2EA81Q60141990-9C7EBCE9-25A7-4D9B-871A-E25675D3782DQ60142011-BB28C482-6154-4139-A0DD-EF53582843A7Q60142033-574D8B20-B435-40A8-A4A7-C9FD647498D3Q92718415-75026A50-3552-48AC-89E9-A29C432612B2Q93132484-B8D333D6-BC34-4BED-A0ED-94F40D1915B4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charlotte S Wilhelm-Benartzi
@ast
Charlotte S Wilhelm-Benartzi
@en
Charlotte S Wilhelm-Benartzi
@es
Charlotte S Wilhelm-Benartzi
@nl
type
label
Charlotte S Wilhelm-Benartzi
@ast
Charlotte S Wilhelm-Benartzi
@en
Charlotte S Wilhelm-Benartzi
@es
Charlotte S Wilhelm-Benartzi
@nl
prefLabel
Charlotte S Wilhelm-Benartzi
@ast
Charlotte S Wilhelm-Benartzi
@en
Charlotte S Wilhelm-Benartzi
@es
Charlotte S Wilhelm-Benartzi
@nl
P106
P21
P31
P496
0000-0003-4927-6158